A systematic review of human challenge trials, designs, and safety

J Adams-Phipps, D Toomey, W Więcek… - Clinical Infectious …, 2023 - academic.oup.com
Background Few studies have assessed participant safety in human challenge trials (HCTs).
Key questions regarding HCTs include how risky such trials have been, how often adverse …

Controlled human infectious models, a path forward in uncovering immunological correlates of protection: Lessons from enteric fevers studies

MB Sztein, JS Booth - Frontiers in microbiology, 2022 - frontiersin.org
Enteric infectious diseases account for more than a billion disease episodes yearly
worldwide resulting in approximately 2 million deaths, with children under 5 years old and …

[HTML][HTML] Vaccine value profile for Salmonella enterica serovar Paratyphi A

LB Martin, F Khanam, F Qadri, I Khalil, MJ Sikorski… - Vaccine, 2023 - Elsevier
In Asia, there are an estimated 12 million annual cases of enteric fever, a potentially fatal
systemic bacterial infection caused by Salmonella enterica serovars Typhi (STy) and …

Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q

P Niewold, DJ Dijkstra, Y Cai, D Goletti, F Palmieri… - Scientific Reports, 2023 - nature.com
Tuberculosis (TB) is a prevalent disease causing an estimated 1.6 million deaths and 10.6
million new cases annually. Discriminating TB disease from differential diagnoses can be …

The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised …

PS Kulkarni, AV Potey, S Bharati, A Kunhihitlu… - The Lancet, 2024 - thelancet.com
Background Enteric fever caused by Salmonella enterica Typhi and Salmonella Paratyphi A
is an important public health problem, especially in low-income and middle-income …

Comparison of strategies for typhoid conjugate vaccine introduction in India: a cost-effectiveness modeling study

T Ryckman, AS Karthikeyan, D Kumar… - The Journal of …, 2021 - academic.oup.com
Background Typhoid fever causes substantial global mortality, with almost half occurring in
India. New typhoid vaccines are highly effective and recommended by the World Health …

Paratyphoid fever A: Infection and prevention

L Xie, L Ming, M Ding, L Deng, M Liu… - Frontiers in …, 2022 - frontiersin.org
Enteric fever is caused by Salmonella enterica serovar Typhi, Salmonella enterica serovar
Paratyphi A, B, and C. While S. Typhi remains the primary causative agent of enteric fever, S …

Early transcriptional responses to human enteric fever challenge

A Barton, J Hill, D O'Connor, C Jones… - Infection and …, 2023 - Am Soc Microbiol
Enteric fever, caused by oral infection with typhoidal Salmonella serovars, presents as a non-
specific febrile illness preceded by an incubation period of 5 days or more. The enteric fever …

Genetic susceptibility to enteric fever in experimentally challenged human volunteers

A Barton, J Hill, S Bibi, L Chen, C Jones… - Infection and …, 2022 - Am Soc Microbiol
Infections with Salmonella enterica serovars Typhi and Paratyphi A cause an estimated 14
million cases of enteric fever annually. Here, the controlled nature of challenge studies is …

Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised …

N McCann, K Emary, N Singh, F Mclean, S Camara… - BMJ open, 2023 - bmjopen.bmj.com
Introduction This is the first efficacy study of an oral live attenuated vaccine against
Salmonella Paratyphi A using a human challenge model of paratyphoid infection. S …